In colon carcinomas, hepatocellular carcinomas, a proportion of breast cancers, prostate cancer, and bladder cancer, CEACAM1 is down-regulated supporting the assumption that CEACAM1 acts in epithelial cells as a growth/tumor suppressor [64,65,66]. Here, CEACAM1 is linked to urinary bladder cancer.